 | |
 | |
| Combination of | |
|---|---|
| Amlodipine | Calcium channel blocker |
| Benazepril | ACE inhibitor |
| Clinical data | |
| Trade names | Lotrel |
| AHFS/Drugs.com | Professional Drug Facts |
| License data | |
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| KEGG | |
| CompTox Dashboard (EPA) | |
  (what is this?) (verify) | |
Amlodipine/benazepril, sold under the brand name Lotrel among others, is a fixed-dose combination medication used to treat high blood pressure. [1] It is a combination of amlodipine, as the besilate, a calcium channel blocker, and benazepril, an angiotensin converting enzyme inhibitor. [1] It may be used if a single agent is not sufficient. [1] It is taken by mouth. [1]
Common side effects include cough, dizziness, and swelling. [1] Serious side effects may include angioedema, myocardial infarction, high blood potassium, liver problems, and low blood pressure. [1] Use in pregnancy is not recommended. [1] Amlodipine works by increasing the size of arteries while benazepril works by decreasing renin-angiotensin-aldosterone system activity. [1]
The combination was approved for medical use in the United States in 1995. [2] It is available as a generic medication. [3] In 2023, it was the 186th most commonly prescribed medication in the United States, with more than 2 million prescriptions. [4] [5]
